Flex Conference (Physical / Digital)

International Symposium on Vaccine Safety, Infectious Diseases and Immunology (ISVSI - 26)

Early Bird
10%OFF
Save up to $30 maximum per registration. Apply at checkout.
Your Code
FAST10

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals.

SDG 3 SDG 3 — Good Health and Well-being
SDG 4 SDG 4 — Quality Education
SDG 6 SDG 6 — Clean Water and Sanitation
SDG 9 SDG 9 — Industry, Innovation and Infrastructure
SDG 10 SDG 10 — Reduced Inequalities
Track 01

Advancements in Vaccine Safety Monitoring

This track focuses on the latest methodologies and technologies in monitoring vaccine safety. Discussions will include adverse event reporting systems and their impact on public health policy.

Track 02

Innovations in Infectious Disease Prevention

This session will explore novel strategies for preventing infectious diseases, including vaccination campaigns and public health initiatives. Emphasis will be placed on case studies demonstrating successful outbreak prevention.

Track 03

Immunological Responses to Vaccination

This track examines the immune mechanisms activated by vaccines and their implications for individual and population health. Researchers will present findings on immune response variability and its impact on vaccine efficacy.

Track 04

Epidemiology of Vaccine-Preventable Diseases

This session will delve into the epidemiological trends of diseases that can be prevented through vaccination. Participants will analyze data on outbreaks and vaccination coverage to inform future public health strategies.

Track 05

Clinical Trials and Vaccine Development

This track will cover the design and implementation of clinical trials for new vaccines. Discussions will include regulatory challenges and ethical considerations in vaccine research.

Track 06

Global Health Strategies for Immunization

This session will explore international efforts to enhance immunization programs in low-resource settings. Key topics will include collaboration between governments and NGOs to improve vaccine access and distribution.

Track 07

Adverse Events Following Immunization: Risk Assessment

This track will focus on the assessment and management of adverse events following immunization. Experts will discuss methodologies for evaluating risks and communicating findings to the public.

Track 08

The Role of Vaccines in Controlling Epidemics

This session will analyze the critical role of vaccines in controlling and preventing epidemic outbreaks. Case studies will highlight successful vaccination campaigns during recent epidemics.

Track 09

Public Perception and Acceptance of Vaccines

This track will investigate factors influencing public perception and acceptance of vaccines. Researchers will present studies on misinformation, trust in healthcare systems, and community engagement strategies.

Track 10

Immunization Programs: Challenges and Solutions

This session will address the challenges faced by immunization programs globally, including logistical, financial, and sociocultural barriers. Participants will share innovative solutions and best practices for overcoming these obstacles.

Track 11

Future Directions in Vaccine Research and Development

This track will explore emerging trends and future directions in vaccine research and development. Topics will include novel vaccine platforms, personalized immunization strategies, and the role of technology in vaccine innovation.

Important Dates

Early Bird Registration :19th July 2026

Paper Submission Deadline :24th July 2026

Last Date of Registration : 3rd August 2026

Date of Conference : 18th - 19th August 2026

Supporting Academic Continuity

APSTE ensures that research and publication processes continue without interruption in the current global situation. Participants can present their work through digital and integrated formats.

Close button will appear in 20s...